Stockreport

Cardiff Oncology, Inc. (CRDF) Discusses Management Transition and Onvansertib Phase II Data Update in RAS-Mutated mCRC Transcript [Seeking Alpha]

Cardiff Oncology, Inc.  (CRDF) 
PDF Company Participants Mani Mohindru Roger Sidhu - Chief Medical Officer Conference Call Participants Marc Frahm - TD Cowen, Research Division Maurice Raycroft [Read more]